This inventor holds 7 USPTO granted patents. Top assignees: Hadasit Medical Research Services and Development Ltd., Insight Biopharmaceuticals Ltd., Bio-Technology General (Israel) Ltd.. Active years: 2003-2011.
Location History:
- Ramat Gan, IL (2003)
- Hasharon, IL (2005)
- Hod Hasharon, IL (2006 - 2011)
Company Filing History:

Years Active: 2003-2011
Title: Tuvia Peretz: Innovator in Heparanase Research
Introduction
Tuvia Peretz is a notable inventor based in Hod Hasharon, Israel. He has made significant contributions to the field of medical research, particularly in the development of molecular probes related to heparanase. With a total of 7 patents to his name, Peretz has established himself as a key figure in his area of expertise.
Latest Patents
One of his latest patents involves the creation of heparanase specific molecular probes and their applications in research and medical fields. This invention provides an antibody that specifically binds to an epitope of a heparanase protein, which includes an amino acid sequence as set forth in SEQ ID NO:2, with phenylalanine replacing tyrosine at position 246. Additionally, he has developed methods for detecting the presence, absence, or level of heparanase expression, showcasing the versatility and importance of his work.
Career Highlights
Throughout his career, Tuvia Peretz has worked with several prominent organizations, including Hadasit Medical Research Services and Development Ltd. and Insight Biopharmaceuticals Ltd. His work in these companies has allowed him to further his research and contribute to advancements in medical science.
Collaborations
Peretz has collaborated with notable colleagues such as Iris Pecker and Israel Vlodavsky. These partnerships have played a crucial role in enhancing the impact of his research and innovations.
Conclusion
Tuvia Peretz is a distinguished inventor whose work in heparanase research has led to significant advancements in medical applications. His contributions continue to influence the field and pave the way for future innovations.